Страница 1 от 29 полученные результаты
TECHNICAL FIELD
The present invention relates to a preventive and/or ameliorative agent for diseases, a stamina enhancement agent, and an anti-fatigue agent, a pharmaceutical and a food and drink, using them.
BACKGROUND ART
It is known that the balance in a network of an immune system, a nervous
The sequence listing in the file named "43272ol1805.txt" having a size of 341,671 bytes that was created Apr. 3, 2014 is hereby incorporated by reference in its entirety.
BACKGROUND
1. Field of the Art
This invention is an extension of Applicants' prior invention disclosed in the above-referenced
FIELD
Curcumin compositions herein are described to improve performance and endurance for normal physical and/or sports activities and to reduce the stress on body systems resulting from these activities. The compositions are comprised of curcumin either alone or along with at least one more
FIELD OF THE INVENTION
The present invention relates to uses of ether phospholipids in treating and preventing various diseases, including, but not limited to, neurodegenerative or brain diseases; metabolic diseases or syndromes; infectious diseases; diseases related to inflammation; heart diseases,
BACKGROUND
In the past six years or so, there has been an increase in research about histamine intolerance, which has generated clinical evidence of it, and more internet sites with options to help those who are intolerant. It is believed that many who are intolerant to histamine can have the
BACKGROUND
In the past six years or so, there has been an increase in research about histamine intolerance, which has generated clinical evidence of it, and more internet sites with options to help those who are intolerant. It is believed that many who are intolerant to histamine can have the
This invention relates to the prevention of the acute post-alcoholic intoxication state, commonly called the alcohol "hangover". A "hangover" results from ingesting a relatively excessive quantity of alcohol, a term understood to refer to alcoholic beverages as well as any particular alcohol found
The present invention is concerned with indolin-2-one derivatives of general formula
##STR00002## wherein A is phenyl or a six membered heteroaryl group, containing one or two N atoms, selected from
##STR00003## or the amine group --NR.sup.1R.sup.2 may form together with two neighboring carbon atoms
The present invention is concerned with indolin-2-one derivatives of general formula
##STR00002## wherein A is phenyl or a five or six membered heteroaryl group, containing one or two N atoms, selected from
##STR00003## or the amide group --C(O)--NR.sup.1R.sup.2 may form together with two
The present invention is concerned with indolin-2-one derivatives of general formula
##STR00004## wherein A is phenyl or a six membered heteroaryl group, containing one or two N atoms, selected from
##STR00005## or the oxygen atom may form together with two neighboring carbon atoms from the group A
The present invention is concerned with indolin-2-one derivatives of general formula
##STR00004## wherein A is phenyl or a six membered heteroaryl group, containing one or two N atoms, selected from
##STR00005## R.sup.1 is S(O).sub.2lower alkyl, S(O).sub.2NR.sup.4R.sup.5, S(O).sub.2cycloalkyl,
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the